Clinical Trial Update: Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ERB-041 for endometriosis in reproductive-age women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• ERB-041

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Endometriosis | Phase 2 | Status: COMPLETED